Skip to main content
. 2017 Jun 19;102(9):3340–3348. doi: 10.1210/jc.2016-4043

Figure 3.

Figure 3.

Effect of low LDL levels on plasma PCSK9: (a) group comparison for total PCSK9 levels in the ANGPTL3 cohort; (b) immunoblot (upper) and quantification (lower) for plasma PCSK9 molecular forms in the ANGPTL3 cohort; (c) group comparison for total PCSK9 levels in the FHBL1 cohort; and (d) Immunoblot (upper) and quantification (lower) for plasma PCSK9 molecular form in the FHBL1 cohort. *P < 0.05, **P < 0.01,***P < 0.001.